Ftse Mib
38.456,17
0,09%
DAX
22.425,93
0,73%
S&P 500
6.008,08
-0,08%
NASDAQ
19.418,45
-0,54%
Bitcoin
94.116,54
-2,24%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Invivyd Inc (IVVD) Invivyd Inc (IVVD) Notizie

Invivyd Inc

IVVD
1,2601
-0,5099 (-28,81%)
Ultimo aggiornamento: 20:52:24
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/2/202513:11EDGAR2Form 8-K - Current report
24/2/202513:05GLOBEFDA Declined Invivyd’s Request to Expand Existing Emergency..
19/2/202522:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202515:19EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
10/2/202513:00GLOBEInvivyd to Present at the Oppenheimer 35th Annual Healthcare..
05/2/202515:30GLOBEInvivyd Announces Partnership with Pro Football Coach Jim..
03/2/202513:05EDGAR2Form 8-K - Current report
03/2/202513:00GLOBEInvivyd Announces Positive Phase 1/2 Clinical Data for..
03/2/202512:55GLOBEInvivyd Announces Preliminary Fourth Quarter 2024 Financial..
27/1/202513:07EDGAR2Form 8-K - Current report
27/1/202513:01GLOBEInvivyd Provides Another Positive SARS-CoV-2 Variant Data..
10/1/202513:08EDGAR2Form 8-K - Current report
10/1/202513:01GLOBEInvivyd Announces Continued Neutralizing Activity of..
27/12/202422:13EDGAR2Form 8-K - Current report
02/12/202421:12EDGAR2Form 8-K - Current report
14/11/202415:16EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202413:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202413:19EDGAR2Form 8-K - Current report
14/11/202413:05GLOBEInvivyd Reports Third Quarter 2024 Financial Results and..
14/11/202413:01GLOBEInvivyd Announces New England Journal of Medicine Publishes..
12/11/202414:30GLOBEInvivyd Announces Preprints Conveying CANOPY Phase 3..
06/11/202414:01GLOBEInvivyd to Participate in the Guggenheim Securities..
06/11/202413:01GLOBEInvivyd to Host Third Quarter 2024 Financial Results and..
29/10/202412:17EDGAR2Form 8-K - Current report
29/10/202412:03GLOBEInvivyd Reports Preliminary Third Quarter 2024 Results,..
29/10/202412:01GLOBEInvivyd Phase 3 Long-Term Exploratory Clinical Efficacy Data..
16/10/202413:01GLOBEInvivyd to Present PEMGARDA™ (pemivibart) Data at Infectious..
01/10/202413:01GLOBEInvivyd Announces U.S. FDA Has Updated the PEMGARDA™ EUA..
23/9/202413:07EDGAR2Form 8-K - Current report
23/9/202413:01GLOBEInvivyd Provides Detailed Virology Data and Analysis of..
12/9/202413:01GLOBEInvivyd at the Ready for Upcoming Respiratory Virus Season..
06/9/202415:05EDGAR2Form 8-K - Current report
05/9/202413:01GLOBEInvivyd to Participate in Upcoming Investor Conferences
04/9/202413:10EDGAR2Form 8-K - Current report
04/9/202413:01GLOBEInvivyd Doses First Participants in Phase 1 Clinical Trial..
03/9/202413:07EDGAR2Form 8-K - Current report
03/9/202413:01GLOBEInvivyd Announces Continued Neutralizing Activity of..
27/8/202414:05EDGAR2Form 8-K - Current report
27/8/202413:01GLOBEInvivyd Announces PEMGARDA™ (pemivibart) Demonstrated 84%..
14/8/202414:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202414:20EDGAR2Form 8-K - Current report
14/8/202414:01GLOBEInvivyd Reports Second Quarter 2024 Financial Results and..
12/8/202422:01GLOBEInvivyd to Host Conference Call Discussing Second Quarter..
01/7/202413:01GLOBEInvivyd Announces its Addition to the Russell 2000® and..
14/6/202413:07EDGAR2Form 8-K - Current report
14/6/202413:01GLOBEInvivyd Announces Antiviral Activity of VYD222 (pemivibart)..
06/6/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 1,30 Min: 1,15 Max: 1,48
Chiusura: 1,77

La tua Cronologia

NASDAQ
IVVD
Invivyd
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci